Ugur Sahin

Ugur Sahin

Chief Executive Officer at BIONTECH SE

Net worth: 3 674 M $ as of 2024-02-28

58 year
Commercial Services
Health Technology
Consumer Services

Profile

Founder of BioNTech SE, Ganymed Pharmaceuticals AG, Ci3 Management UG and TRON - Translationale Onkologie an der Universitätsmedizin der, Ugur Sahin currently is Chief Executive Officer for BioNTech SE and Managing Director at reBOOST Management GmbH (a subsidiary of BioNTech SE) and Managing Director at Medine GmbH. Dr. Sahin is also Professor at Universitätsmedizin der Johannes Gutenberg-Universität Mainz. He previously occupied the position of Chief Medical Officer for Ganymed Pharmaceuticals AG and Co-Managing Director at TRON - Translationale Onkologie an der Universitätsmedizin der. Dr. Sahin received a doctorate from Universität zu Köln.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2023-12-30 41,295,728 ( 17.10% ) 3 674 M $ 2024-02-28

Ugur Sahin active positions

CompaniesPositionStart
BIONTECH SE Chief Executive Officer 2008-06-01
Chief Executive Officer 2018-10-22
Chief Executive Officer 2011-03-13
Corporate Officer/Principal 2013-12-31
Helmholtz Institute For Translational Oncology Corporate Officer/Principal -
Chief Executive Officer -
All active positions of Ugur Sahin

Former positions of Ugur Sahin

CompaniesPositionEnd
Chief Executive Officer 2018-12-31
Founder 2010-07-29
Ci3 Management UG Founder -
See the detail of Ugur Sahin's experience

Training of Ugur Sahin

Universität zu Köln Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Ugur Sahin's experience

Connections

81

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies1
BIONTECH SE

Health Technology

Private companies8

Health Technology

Health Services

Ci3 Management UG

Commercial Services

Commercial Services

Commercial Services

Commercial Services

Helmholtz Institute For Translational Oncology

See company connections
  1. Stock
  2. Insiders
  3. Ugur Sahin